Generating milestone and royalty income
First written in FY2024. 2 of 5 entries say "Advanced", first in FY2026-H1. Latest entry: FY2027-H1.
The whole theme swung hardest in 2019: 2 of 6 companies on the "Worse" side.
13 other companies' latest entry also says "Restated".
- FY2027-H1RestatedAnnual report
「Milestone income ¥465,870 thousand」
Milestone income of ¥465,870 thousand was also recognized during the interim accounting period, continuing the revenue model that includes milestone income. There is no mention of a new partnership or future royalties. - 2026-03-27Cited as achievedManagement Planning
「During the partnership period, each pipeline advanced significantly in terms of business stage while milestone payments were received.」
The Company cited its receipt of milestone payments during the former partnership period as evidence of progress in the business stages of its pipelines. - FY2025AdvancedAnnual report
「Revenue was ¥3,026,500 thousand. This was because revenue was recognized based on the development milestone achieved under the exclusive technology partnership and license agreement with Novo Nordisk A/S.」
The Company recognized ¥3,025,000 thousand in milestone income for the fiscal year following achievement of development milestones during the partnership with Novo Nordisk. The termination of the partnership changed the assumptions underlying future royalty income. - FY2026-H1AdvancedAnnual report
「As a result of achieving a development milestone under the exclusive technology partnership and license agreement with Novo Nordisk A/S, based on the recent business progress during the interim accounting period, milestone income has been recognized as revenue.」
Milestone income of ¥1,917,850 thousand was recognized as revenue during the interim accounting period following achievement of a development milestone. This represents realization of a specific milestone payment, not completion of the overall revenue model. - FY2024First statedAnnual report
「Upfront fees and various milestone payments will total up to US$598 million, while after commercial launch overseas, we will also receive royalties in the high single digits to low double digits as a percentage of annual net sales overseas, increasing progressively with sales.」
The Company has established a revenue model combining upfront fees, development, approval and sales milestones, and royalties.